Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uveitis masquerade syndromes.

A Rothova1, F Ooijman, F Kerkhoff

  • 1F.C. Donders Institute of Ophthalmology, University Medical Center, Utrecht, The Netherlands. A.Rothova@oogh.azu.nl

Ophthalmology
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of conjunctival, episcleral and scleral thickness in healthy individuals using anterior segment optical coherence tomography.

Acta ophthalmologica·2023
Same author

Subconjunctival Rituximab Administration for the Treatment of Scleritis.

Ocular immunology and inflammation·2022
Same author

Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis.

Ocular immunology and inflammation·2021
Same author

Recurrences of Scleritis after Ocular Surgery.

Ocular immunology and inflammation·2021
Same author

Current insights in the pathogenesis of scleritis.

Experimental eye research·2020
Same author

Successful Tocilizumab Treatment for Scleritis.

Ocular immunology and inflammation·2019
Same journal

Value of 10-2 Visual Field Testing for Detecting Progression in Patients with Glaucoma.

Ophthalmology·2026
Same journal

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis.

Ophthalmology·2026
Same journal

Diverse Conjunctival Adverse Events Associated with Tisotumab Vedotin.

Ophthalmology·2026
Same journal

The Answer Is Blowing in the Wind: Uncovering Hidden Glaucoma Risk Factors.

Ophthalmology·2026
Same journal

Nonsteroidal Anti-inflammatory Drug Use Reduces the Risk of Age-Related Macular Degeneration in Electronic Health Record Analysis: Signal or Solution?

Ophthalmology·2026
Same journal

Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

Ophthalmology·2026
See all related articles

Uveitic masquerade syndromes (UMS) are rare, but a significant portion are malignant or vascular diseases. Early diagnosis through specific tests like intraocular fluid analysis is crucial for patient survival.

Area of Science:

  • Ophthalmology
  • Medical Diagnostics
  • Oncology

Background:

  • Uveitic masquerade syndromes (UMS) can be misdiagnosed, leading to severe patient outcomes.
  • This study investigates the frequency, clinical features, and diagnostic methods for UMS.

Observation:

  • Forty patients with UMS were identified from 828 uveitis cases over a mean follow-up of 4.5 years.
  • Clinical, laboratory, photographic, and angiographic data were retrospectively analyzed.

Findings:

  • Intraocular malignancy (48%) and vascular diseases were frequent causes of UMS.
  • Intraocular fluid analysis and fluorescein angiography were key diagnostic procedures for malignant and non-malignant UMS, respectively.
  • Malignant UMS patients were older and had a higher mortality rate.

Related Experiment Videos

Implications:

  • Timely diagnosis of UMS is critical for both visual preservation and patient survival.
  • Increased awareness of UMS clinical presentations and appropriate diagnostic testing are essential.
  • Ophthalmologists play a key role in the initial recognition of malignant conditions presenting as UMS.